SenzaGen renews and expands global collaboration agreement with Charles River Laboratories
SenzaGen has renewed and expanded its global collaboration agreement with the contract research organization Charles River Laboratories, one of the world's leading companies in laboratory services. To meet the growing interest in risk assessment of chemicals by using SenzaGen's non-animal test platform GARD®, the collaboration was broadened to now include all tests in the GARD portfolio.
Charles River Laboratories International, Inc. is a leading global contract research organization offering preclinical laboratory services to the pharmaceutical, chemical, agrochemical and medical device industries, among others. Companies in these industries are increasingly looking for alternative test methods that are more precise and cost-effective in the long run. The collaboration with SenzaGen was initiated in 2017.
“We are very pleased with our continued and expanded collaboration with Charles River Laboratories and to work with them to drive the change in establishing alternative testing methods widely. The collaboration is in line with our commercial strategy to form a global partner network and Charles River Laboratories is a leading service provider to the industries we prioritize, giving us a very strong sales channel. The fact that Charles River Laboratories continue to offer GARD to their customers and include our latest developed tests confirms the strength of our technology,” says Axel Sjöblad, CEO of SenzaGen.
“At Charles River we are passionate about our role in improving the quality of people´s lives and we strive at providing the best scientific solutions. We are happy to continue our collaboration with SenzaGen to offer the state-of-the-art GARD technology for sensitization assessments. Since 2017, our customers have been requesting GARD sensitization services and appreciate its unique ability to provide potency classification according to CLP, among other features”, says Walter Westerink, Section Head Flexible Innovation Team, Charles River Laboratories.